APYX
Apyx Medical CorpCompany with tickers: APYX
CIK
719135
CUSIP
03837C106
Shares Outstanding
41,873,951
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $12,490,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | $7,925,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $8,836,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $765,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-911,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-2,108,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.05 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | — |